Company: HRTX
Filing Date: 2025-04-30
Form Type: DEF 14A
Source: 0000950170-25-060882
Chunk: 9

Company: HERON THERAPEUTICS, INC. /DE/
Filing Date: 2025-04-30
Form: DEF 14A
Chunk 9
---
 (“Proposal 3”), and the approval of the frequency of future stockholder advisory votes on the compensation paid to our Named Executive Officers (“Proposal 4”) are considered as “non-routine” matters under applicable stock exchange rules. We therefore expect broker non-votes to exist in connection with Proposals 1, 3, and 4.

The ratification of the appointment of Withum as our independent registered public accounting firm for the fiscal year ending December 31, 2025 (“Proposal 2”) is considered a “routine” matter under applicable rules. A broker or other nominee may generally vote on routine matters, so we do not expect there will be any broker non-votes with respect to Proposal 2.

How are votes counted and how many votes are needed to approve each proposal?

Votes will be counted by the Inspector of Elections appointed for the Annual Meeting. The following are the voting requirements for each proposal:

Proposal 1: Director nominees shall be elected by a majority of the votes cast with respect to that director nominee, provided a quorum is established.

Proposal 2: The proposal to ratify the appointment of Withum as our independent registered public accounting firm for the year ending December 31, 2025 requires the affirmative vote of a majority of the votes properly cast on the proposal, provided a quorum is established.

Proposal 3: The proposal to approve, on a nonbinding, advisory basis, the compensation paid to our Named Executive Officers requires the affirmative vote of a majority of the votes properly cast on the proposal, provided a quorum is established.

Proposal 4: On the proposal to approve, on a nonbinding advisory basis, the frequency of future advisory votes on the compensation paid to our Named Executive Officers, stockholders will have the opportunity to choose among four options (holding the vote every one, two or three years, or abstain) and, therefore, stockholders will not be voting to approve or disapprove the proposal.

There are no appraisal or dissenter’s rights with respect to the matters to be acted upon at the Annual Meeting.

How are abstentions and broker non-votes treated?

Broker non-votes and abstentions are counted for purposes of determining whether a quorum is present at the Annual Meeting. Our bylaws provide that broker non-votes are not counted as votes "cast" either "for" or "against" a director nominee (Proposal 1) and that broker non-votes are excluded from votes "cast" on Proposal 3 and 4. Broker non-v